Form 4: Vita Coco Company COO Jonathan Burth Sells 10,000 Shares
SEC Form 4
Jonathan Burth, Chief Operating Officer of Vita Coco Company, sold 10,000 shares of common stock on March 3, 2025, at a weighted average price of $32.691 per share.
Summary
- On March 3, 2025, Jonathan Burth, the Chief Operating Officer of Vita Coco Company, sold 10,000 shares of the company's common stock.
- The sale was executed at a weighted average price of $32.691 per share, with individual transactions ranging from $31.98 to $33.05.
- Following the transaction, Burth directly owns 94,108 shares of Vita Coco Company.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan.
- Burth also holds multiple non-qualified stock options, which are rights to buy common stock at various exercise prices and vesting schedules.
Sentiment
Score: 5
Explanation: The sentiment is neutral. It's a routine Form 4 filing for an insider stock sale under a pre-arranged plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Insider sales are a common occurrence and are often scrutinized by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, sales under 10b5-1 plans are pre-arranged and may not reflect current sentiment.
Comparison to Industry Standards
- Comparing this transaction to similar insider sales in the beverage industry is difficult without more context.
- Companies like National Beverage Corp. (FIZZ) and Monster Beverage Corp. (MNST) are competitors, but insider trading activity varies based on individual circumstances and company policies.
- Generally, insider sales are compared to historical trading patterns within the same company and against industry averages to gauge significance.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 trading plan mitigates this concern.
- The impact on employees, customers, suppliers, and creditors is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 11/27/2022 | Start date of vesting for one of the stock option grants. |
| 03/10/2024 | Start date of vesting for one of the stock option grants. |
| 08/15/2025 | Start date of vesting for one of the stock option grants. |
| 03/04/2025 | Start date of vesting for one of the stock option grants. |
| 03/03/2025 | Date of stock sale. |
| 03/05/2025 | Date of report. |
| 12/16/2029 | Expiration date for one of the stock option grants. |
| 02/10/2030 | Expiration date for one of the stock option grants. |
| 01/11/2031 | Expiration date for one of the stock option grants. |
| 10/21/2031 | Expiration date for one of the stock option grants. |
| 08/15/2032 | Expiration date for one of the stock option grants. |
| 03/10/2033 | Expiration date for one of the stock option grants. |
| 03/04/2034 | Expiration date for one of the stock option grants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.